Annual Report

Overview

The report presents Traphaco's 2024 performance across pharmaceutical growth, digital transformation, governance and sustainability. It highlights deployed order-center, traceability, HR-management, sales and e-learning systems, alongside new product and bioequivalence achievements. The management section reports consolidated net revenue of 2,370.2 Billion VND and consolidated profit after tax of 257.3 Billion VND. Its sustainability section reports GRI in-accordance reporting, workforce information, and environmental and occupational-safety activities.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size
Restatement: Disclosed

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Level
Standard
Scope
Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services